lanthionine ketimine has been researched along with Disease Models, Animal in 6 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hensley, K; Ohshima, T; Yazawa, A | 1 |
| Goshima, Y; Hasegawa, M; Hensley, K; Kotaka, K; Masukawa, D; Nagai, J; Ohshima, T; Takahashi, M; Togashi, K; Yazawa, A | 1 |
| Baxter, T; Benda, E; Hardin, T; Hensley, K; Holgado, AM; Hubbard, C; O'Brien, S; St John, E | 1 |
| Eslami, P; Gabbita, SP; Harris-White, ME; Hensley, K; Hristov, A; Johnson, MF; Venkova, K | 1 |
| Eslami, P; Gabbita, SP; Harris-White, ME; Hensley, K; Hristov, AM; Johnson, MF; Poteshkina, A; Venkova-Hristova, KM | 1 |
| Hensley, K; Kotaka, K; Nagai, J; Ohshima, T | 1 |
6 other study(ies) available for lanthionine ketimine and Disease Models, Animal
| Article | Year |
|---|---|
Effects of Lanthionine Ketimine-5-Ethyl Ester on the α-Synucleinopathy Mouse Model.
Topics: alpha-Synuclein; Amino Acids, Sulfur; Animals; Disease Models, Animal; Esters; Humans; Mice; Mice, Transgenic; Synucleinopathies | 2022 |
Lanthionine ketimine ester improves outcome in an MPTP-induced mouse model of Parkinson's disease via suppressions of CRMP2 phosphorylation and microglial activation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acids, Sulfur; Animals; Disease Models, Animal; Dopaminergic Neurons; Esters; Mice; Mice, Inbred C57BL; Microglia; Parkinson Disease; Phosphorylation; Substantia Nigra | 2020 |
Lanthionine ketimine ethyl ester partially rescues neurodevelopmental defects in unc-33 (DPYSL2/CRMP2) mutants.
Topics: Age Factors; Amino Acids, Sulfur; Analysis of Variance; Animals; Animals, Genetically Modified; Bacterial Proteins; Brain Diseases; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Developmental Disabilities; Disease Models, Animal; GABAergic Neurons; Locomotion; Longevity; Luminescent Proteins; Mutation; Nerve Growth Factors; Nervous System; Neuroprotective Agents | 2013 |
A derivative of the brain metabolite lanthionine ketimine improves cognition and diminishes pathology in the 3 × Tg-AD mouse model of Alzheimer disease.
Topics: Alzheimer Disease; Amino Acids, Sulfur; Animals; Behavior, Animal; Brain; Cell Line, Tumor; Cognition; Disease Models, Animal; Female; Male; Maze Learning; Mice; Mice, Transgenic; Nesting Behavior; Neurons; Phosphorylation | 2013 |
Autophagy Modulation by Lanthionine Ketimine Ethyl Ester Improves Long-Term Outcome after Central Fluid Percussion Injury in the Mouse.
Topics: Amino Acids, Sulfur; Animals; Autophagy; Diffuse Axonal Injury; Disease Models, Animal; Mice; Mice, Inbred C57BL | 2016 |
Lanthionine ketimine ester promotes locomotor recovery after spinal cord injury by reducing neuroinflammation and promoting axon growth.
Topics: Amino Acids, Sulfur; Animals; Anti-Inflammatory Agents, Non-Steroidal; Axons; Biomarkers; Cells, Cultured; Disease Models, Animal; Female; Inflammation; Locomotion; Mice; Mice, Inbred C57BL; Microglia; Neurites; Recovery of Function; Serotonin; Spinal Cord; Spinal Cord Injuries | 2017 |